Drug
Alpha tocopherol
Alpha tocopherol is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
2
40%
Ph phase_1
1
20%
Ph phase_3
1
20%
Phase Distribution
1
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Other(1)
Detailed Status
Completed4
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (25.0%)
Phase 22 (50.0%)
Phase 31 (25.0%)
Trials by Status
completed480%
unknown120%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women
NCT00862433
completedphase_2
Effect of Alpha Tocopherol and Psyllium on Lipid Levels in Dyslipidaemia Patients
NCT07610304
completedphase_2
Effectiveness of Ascorbic Acid and Tocopherol for Depression in Elderly.
NCT02793648
completed
Oxidative Stress and Hemodialysis Access Failure
NCT00410449
unknownphase_3
Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients
NCT01061320
Clinical Trials (5)
Showing 5 of 5 trials
NCT00862433Phase 1
Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women
NCT07610304Phase 2
Effect of Alpha Tocopherol and Psyllium on Lipid Levels in Dyslipidaemia Patients
NCT02793648Phase 2
Effectiveness of Ascorbic Acid and Tocopherol for Depression in Elderly.
NCT00410449
Oxidative Stress and Hemodialysis Access Failure
NCT01061320Phase 3
Efficacy of Alpha Tocopherol for Prevention of Contrast-induced Nephropathy in Chronic Kidney Disease (CKD) Patients
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5